Corcept Therapeutics (CORT) Tops Q2 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Corcept Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
August 2, 2016 4:05 PM EDTMENLO PARK, CA -- (Marketwired) -- 08/02/16 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)
Second quarter revenue of $19.7 million, a 65 percent increase from the second quarter of 2015 Second quarter GAAP net income of $0.01 per share, compared to a GAAP net loss of $0.02 per share in the second quarter of 2015 Excluding non-cash expenses, second quarter non-GAAP net income of $0.03 per share, compared to non-GAAP net income of $0.00 per share in the second quarter of 2015 Cash balance at June 30 increases to $41.8 million Company reiterates its 2016 revenue guidance of $76-81 million... More